Navigation Links
St. Jude influenza survey uncovers key differences between bird flu and human flu
Date:8/20/2007

m identified 32 specific locations in proteins where a gene mutation caused the existing amino acid to be substituted with a different amino acid. What made these 32 changes special was that influenza from birds differed from the influenza that was in humans. After the avian influenza infected humans, the amino acid changes are stable in the proteins and remain stable over time. Therefore, these markers can be used to distinguish influenza viruses that infect birds from those that infect humans.

The researchers discovered these markers by computationally surveying the sequence of amino acids in 10,671 proteins from avian influenza viruses and 13,757 proteins from human influenza viruses. The survey identified 32 persistent markers that exist in five bird and human virus proteins: PA, NP, M1, NS1 and PB2. These markers stand out as obvious differences between bird and human viruses, and many appear in regions where host protein and viral replication occur. The researchers did not determine what functional role the markers play in the life of the viruses.

For example, 26 of the 32 markers discovered are found in NP, PB2 and PA, which help to form a complex of proteins critical for the replication of virus genes. The other six persistent host markers are in M1 and NS1 proteins. M1 is known to bind to a protein in cells that enhances the replication of viruses; and NS1 plays a role in suppressing the host immune response. Therefore, the markers in M1 and NS1 might represent key mutations needed to improve the ability of the virus to suppress the immune system and enhance viral replication.

The St. Jude team also studied markers in influenza viruses that caused pandemics in 1918, 1957 and 1968outbreaks thought to have been caused by avian influenza viruses that adapted to humans. The study focused on the viruses isolated from humans early in each pandemic in order to determine which markers the viruses had recently acquired just before t
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-495-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Computers to be used to find blueprint for new influenza drug
2. Influenza vaccine uses insect cells to speed development
3. Drug resistant avian influenza viruses more common in Southeast Asia than North America
4. Genome Sequence for Haemophilus Influenzae Completed
5. Less virulent strains of avian influenza can infect humans
6. Confronting Influenza: Are We Prepared?
7. New vaccine platform may fight infections with causes from influenza to bioterrorism
8. First big influenza genome study reveals flu evolution
9. Web model of influenza-host lifecycles will aid scientists in creating anti-viral drugs
10. New influenza vaccine takes weeks to mass produce
11. Study outlines genetic differences between potential pandemic influenza strains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium continues to attract ... from industry and academia with the goal of eradicating ... scientists and other professionals will gather at the Henry ... 9-13, 2009. The symposium is a partnership between the ...
(Date:12/3/2009)... dwellers must be included in the design of the upcoming ... crisis, according to a scientist at the University of Leeds. ... Lewis argues that at least 50% of the carbon credit ... Emissions from Deforestation and Degredation), should be made to forest ...
(Date:12/2/2009)... an increased risk of developing lung cancer in adulthood, even ... are published in Cancer Epidemiology, Biomarkers & Prevention , ... part of a special tobacco focus in the December issue. ... be diagnosed with lung cancer; more than 159,000 will die ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Jupiter Medical Center Announces New High Definition MRI System 6690 1Jupiter Medical Center Announces New High Definition MRI System 6690 2Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 1Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 2Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 3Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 4Media alert 3A EUROECHO 2009 62468 1Media alert 3A EUROECHO 2009 62468 2
... National Institutes of Health (NIH) has selected the ... the Genes, Environment and Health Initiative (GEI), a ... , "This is ground-breaking research in understanding the ... said Department of Health and Human Services Secretary ...
... Reader to be the Latest Addition to M2SYS, ... ... Technology, a biometric,technology research and development firm, announced today its ... Plus. The Hamster Plus fingerprint reader features innovative Auto-On,technology ...
... N.Y., Aug. 15 bioMETRX, Inc. (OTC,Bulletin Board: BMRX), ... announced that it is has provided notice to,certain holders ... holders,must surrender said warrants to the company by August ... series B $0.10 warrants that it,has elected to pay ...
Other Biology News:Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 2Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 3Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 4Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 5Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 6Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 7Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 8Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 9M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2bioMETRX, Inc. Calls Series B Warrants 2
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Drug Discovery Technologies ... & Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... and ongoing element of every pharmaceutical company,s ...
(Date:12/2/2009)... first concept demonstration tires made with BioIsoprene ... ingredient in the manufacture of synthetic rubber with renewable ... One tire will be on display at a lounge ... Airport throughout December 21, while the other tire will ...
(Date:12/2/2009)... Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or ... in connection with its previously announced unit offering, the ... purchased an additional 637,500 units. Each unit is comprised ... share purchase warrant, and was sold at a price ...
(Date:12/2/2009)... NV,the Netherlands based biotechnology company focusing on protein mimicking,technology ... it,has appointed Wim E.M. Mol, Ph.D. as new Chief ... will be responsible for all of Pepscans corporate functions ... He brings to,Pepscan more than 20 years of management ...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
... ... First Non-GAAP Profit; Sales Guidance Revised Upward, ... and Cancer, First Quarter 2008 Financial Highlights:, - Soliris(R) (eculizumab) net product sales were $45.5 ... 2007., - Q1 GAAP net loss was $4.2 million, or $0.11 net loss per share, compared ...
... Inc. (Nasdaq: SEPR ), FRAMINGHAM, Mass. ... HTW) today announced that,veteran healthcare executive Timothy J. ... non- executive director, effective immediately., Barberich, 60, ... and chairman of Marlborough, MA-based Sepracor Inc., a ...
... 29 RediClinic LLC announced today,that it is ... Inc.,to provide free diabetes screenings to school age ... identify diabetic and pre-diabetic children and,adolescents. Beginning May ... the,diabetes screenings will be available free of charge ...
Other Biology Technology:Alexion Reports First Quarter 2008 Results 2Alexion Reports First Quarter 2008 Results 3Alexion Reports First Quarter 2008 Results 4Alexion Reports First Quarter 2008 Results 5Alexion Reports First Quarter 2008 Results 6Alexion Reports First Quarter 2008 Results 7Alexion Reports First Quarter 2008 Results 8Alexion Reports First Quarter 2008 Results 9Alexion Reports First Quarter 2008 Results 10Alexion Reports First Quarter 2008 Results 11Alexion Reports First Quarter 2008 Results 12HeartWare Appoints Timothy J. Barberich to Board of Directors 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 3RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 4RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 5
Mouse monoclonal [CP23] to Ricin communis ( Abpromise for all tested applications)....
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: